Thirty years after scientists coined the term “hygiene hypothesis” to suggest that increased exposure to microorganisms could benefit health, CU Boulder researchers have identified an anti-inflammatory fat in a soil-dwelling bacterium that may be responsible.
The discovery, published Monday in the journal Psychopharmacology, may at least partly explain how the bacterium, Mycobacterium vaccae, quells stress-related disorders. It also brings the researchers one step closer to developing a microbe-based “stress vaccine.”
“We think there is a special sauce driving the protective effects in this bacterium, and this fat is one of the main ingredients in that special sauce,” said senior author and Integrative Physiology Professor Christopher Lowry.
British scientist David Strachan first proposed the controversial “hygiene hypothesis” in 1989, suggesting that in our modern, sterile world, lack of exposure to microorganisms in childhood was leading to impaired immune systems and higher rates of allergies and asthma. Researchers have since refined that theory, suggesting that it is not lack of exposure to disease-causing germs at play, but rather to “old friends”—beneficial microbes in soil and the environment that we have long lived alongside—and that mental health is also impacted.
We are just beginning to see the tip of the iceberg in terms of identifying the mechanisms through which bacteria evolved to keep us healthy. It should inspire awe in all of us.”
“The idea is that as humans have moved away from farms and an agricultural or hunter-gatherer existence into cities, we have lost contact with organisms that served to regulate our immune system and suppress inappropriate inflammation,” said Lowry. “That has put us at higher risk for inflammatory disease and stress-related psychiatric disorders.”
Lowry has published numerous studies demonstrating a link between exposure to healthy bacteria and mental health. One showed that children raised in a rural environment, surrounded by animals and bacteria-laden dust, grow up to have more stress-resilient immune systems and may be at lower risk of mental illness than pet-free city dwellers.
Others have shown that when a particular soil-dwelling bacterium, Mycobacterium vaccae, is injected into rodents, it alters the animals’ behavior in a way similar to that of antidepressants and has long-lasting anti-inflammatory effects on the brain. (Studies suggest exaggerated inflammation boosts risk of trauma and stressor related disorders, such as posttraumatic stress disorder.)
One Lowry-authored study, published in the Proceedings of the National Academy of Sciences in 2016, showed that injections of M. vaccae prior to a stressful event could prevent a “PTSD-like” syndrome in mice, fending off stress-induced colitis and making the animals act less anxious when stressed again later.
“We knew it worked, but we didn’t know why,” said Lowry. “This new paper helps clarify that.”
For the new study, Lowry and his team identified, isolated and chemically synthesized a novel lipid, or fatty acid, called 10(Z)-hexadecenoic acid found in Mycobacterium vaccae and used next-generation sequencing techniques to study how it interacted with macrophages, or immune cells, when the cells were stimulated.
They discovered that inside cells, the lipid acted like a key in a lock, binding to a specific receptor, peroxisome proliferator-activated receptor (PPAR), and inhibiting a host of key pathways which drive inflammation. They also found that when cells were pre-treated with the lipid they were more resistant to inflammation when stimulated.
“It seems that these bacteria we co-evolved with have a trick up their sleeve,” said Lowry. “When they get taken up by immune cells, they release these lipids that bind to this receptor and shut off the inflammatory cascade.”Lowry has long envisioned developing a “stress vaccine” from M. vaccae, which could be given to first responders, soldiers and others in high-stress jobs to help them fend off the psychological damage of stress.“This is a huge step forward for us because it identifies an active component of the bacteria and the receptor for this active component in the host,” he said.
Simply knowing the mechanism of action by which M. vaccae reaps benefits could boost confidence in it as a potential therapeutic. And if further studies show the novel fat alone has therapeutic effects, that molecule could become a target for drug development, he said.
Overall, the study offers further proof that our “old friends” have a lot to offer.
“This is just one strain of one species of one type of bacterium that is found in the soil but there are millions of other strains in soils,” Lowry said. “We are just beginning to see the tip of the iceberg in terms of identifying the mechanisms through which they have evolved to keep us healthy. It should inspire awe in all of us.”
Learn more: Healthy, stress-busting fat found hidden in dirt
The Latest on: Stress vaccine
via Google News
The Latest on: Stress vaccine
- How to overcome vaccine skepticismon November 28, 2020 at 11:58 pm
Pharmaceutical companies Pfizer and BioNtech announced Nov. 20 that they will seek emergency use authorization from the Food and Drug Administration for a vaccine to prevent covid-19. On Nov. 16, ...
- Airlines preparing to transport COVID-19 vaccine when ready for distributionon November 28, 2020 at 10:48 pm
There isn't an approved COVID-19 vaccine just yet, but preparations are already underway for its distribution-- including any extreme temperature requirements. American Airlines announced this week ...
- Fort Worth-based American Airlines readies to ship COVID-19 vaccineon November 28, 2020 at 4:00 pm
American Airlines said in a statement Friday it successfully completed a trial flight testing the airline's thermal packaging and stress test processes.
- Britain moving forward with vaccine planson November 28, 2020 at 2:59 am
Britain asked its drug regulator Friday to consider AstraZeneca's coronavirus vaccine for emergency approval, forging ahead in the face of uncertainty about the vaccine's effectiveness as the ...
- Frankfurt Pharma Hub Prepares For Covid Vaccine Taskon November 27, 2020 at 10:58 pm
As a string of Covid-19 vaccines near approval, Frankfurt Airport staff are gearing up to handle the unprecedented logistical challenge of transporting millions of life-saving doses worldwide.
- Opinion: Teachers Should Be Among the First to Receive COVID Vaccineson November 27, 2020 at 9:05 pm
Teachers should be given top priority in COVID-19 vaccinations so they can get back into the classroom and teach—for the benefit of our students.
- Britain Set to Leap Ahead in Approving Vaccineson November 27, 2020 at 11:25 am
Regulators may approve the troubled AstraZeneca vaccine and the American-made Pfizer shot weeks before the U.S. does so.
- Will COVID-19 vaccines protect us? Does efficacy equal effectiveness?on November 27, 2020 at 10:05 am
There is a difference between efficacy rates obtained in clinical trials and effectiveness — the real-world protection rate of a vaccine when it is rolled out.
- South Korea foils North Korea attempt to hack COVID-19 vaccine makerson November 27, 2020 at 3:52 am
South Korea's intelligence agency foiled North Korean attempts to hack into South Korean companies developing coronavirus vaccines, lawmakers said on Friday.
- Virus Updates: AstraZeneca Defends Its Vaccine; Ravens QB Jackson Tests Positiveon November 27, 2020 at 12:06 am
As the United States nears 13 million confirmed cases of the coronavirus, millions of Americans are traveling for the Thanksgiving holiday, despite warnings from health officials to stay home and keep ...
via Bing News